156 related articles for article (PubMed ID: 21501548)
1. Pharmacology for common urologic diseases: 2011 review for the primary care physician.
Liu XS; Folia C; Gomella LG
Can J Urol; 2011 Apr; 18 Suppl():24-38. PubMed ID: 21501548
[TBL] [Abstract][Full Text] [Related]
2. Uropharmacology in primary care: 2010 update.
Gomella LG; Lallas CD; Perkel R; Folia C; Hirsch I; Das A; Shenot P
Can J Urol; 2010 Feb; 17 Suppl 1():35-51. PubMed ID: 20170599
[TBL] [Abstract][Full Text] [Related]
3. [The use of alpha-receptor blockers in urological diseases].
Heimbach D; Frohmüller H
Dtsch Med Wochenschr; 1992 May; 117(21):825-8. PubMed ID: 1375139
[No Abstract] [Full Text] [Related]
4. Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice.
Yassin A; Saad F; Hoesl CE; Traish AM; Hammadeh M; Shabsigh R
Andrologia; 2006 Feb; 38(1):1-12. PubMed ID: 16420236
[TBL] [Abstract][Full Text] [Related]
5. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: who are the high-risk patients and what are the best treatment options?
Robert G; Descazeaud A; de la Taille A
Curr Opin Urol; 2011 Jan; 21(1):42-8. PubMed ID: 21045706
[TBL] [Abstract][Full Text] [Related]
6. Uropharmacology for the primary care physician.
Gittens PR; Lallas CD; Pe ML; Perkel R; Folia C; Gomella LG
Can J Urol; 2008 Aug; 15 Suppl 1():78-91; discussion 91. PubMed ID: 18700069
[TBL] [Abstract][Full Text] [Related]
7. An algorithm for medical management in male lower urinary tract symptoms.
Djavan B; Margreiter M; Dianat SS
Curr Opin Urol; 2011 Jan; 21(1):5-12. PubMed ID: 21045704
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic Therapy in Men's Health: Hypogonadism, Erectile Dysfunction, and Benign Prostatic Hyperplasia.
Berkseth KE; Thirumalai A; Amory JK
Med Clin North Am; 2016 Jul; 100(4):791-805. PubMed ID: 27235615
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of pharmacological management of nocturia with non-antidiuretic agents: does statistically significant equal clinically significant?
Smith AL; Wein AJ
BJU Int; 2011 May; 107(10):1550-4. PubMed ID: 21518417
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: the best of both worlds.
Wong P; Lawrentschuk N; Bolton DM
Curr Opin Urol; 2009 Jan; 19(1):7-12. PubMed ID: 19057210
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification for benign prostatic hyperplasia (BPH) treatment.
Emberton M; Fitzpatrick JM; Rees J
BJU Int; 2011 Mar; 107(6):876-80. PubMed ID: 21265993
[TBL] [Abstract][Full Text] [Related]
12. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.
Lowe FC
Clin Ther; 2004 Nov; 26(11):1701-13. PubMed ID: 15639685
[TBL] [Abstract][Full Text] [Related]
13. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
14. Treatment of erectile dysfunction and lower urinary tract symptoms by phosphodiesterase inhibitors.
Uckert S; Stief CG
Handb Exp Pharmacol; 2011; (204):307-22. PubMed ID: 21695646
[TBL] [Abstract][Full Text] [Related]
15. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
Carson CC
BJU Int; 2006 Apr; 97 Suppl 2():39-43; discussion 44-5. PubMed ID: 16507053
[TBL] [Abstract][Full Text] [Related]
16. A report from the 29th Annual Congress of the European Association of Urology (April 11-15 - Stockholm, Sweden).
Rabasseda X
Drugs Today (Barc); 2014 May; 50(5):385-95. PubMed ID: 24918838
[TBL] [Abstract][Full Text] [Related]
17. Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management.
Barkin J
Can J Urol; 2011 Apr; 18 Suppl():14-9. PubMed ID: 21501546
[TBL] [Abstract][Full Text] [Related]
18. Common approach to managing lower urinary tract symptoms and erectile dysfunction.
Taylor JM; Desouza R; Wang R
Asian J Androl; 2008 Jan; 10(1):45-53. PubMed ID: 18087643
[TBL] [Abstract][Full Text] [Related]
19. [Update of the usefulness of α-blockers in the treatment of different urologic pathologies].
Hernández Fernández C; Brenes Bermúdez F; Moncada Iribarren I
Med Clin (Barc); 2012 Dec; 139(13):582-7. PubMed ID: 22982131
[TBL] [Abstract][Full Text] [Related]
20. Association of lower urinary tract symptoms and erectile dysfunction: pathophysiological aspects and implications for clinical management.
Orabi H; Albersen M; Lue TF
Int J Impot Res; 2011; 23(3):99-108. PubMed ID: 21593760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
